Citation: Jt. Hancock et al., Does the redox status of cytochrome C act as a fail-safe mechanism in the regulation of programmed cell death?, FREE RAD B, 31(5), 2001, pp. 697-703
Authors:
Desikan, R
Hancock, JT
Ichimura, K
Shinozaki, K
Neill, SJ
Citation: R. Desikan et al., Harpin induces activation of the arabidopsis mitogen-activated protein kinases AtMPK4 and AtMPK6, PLANT PHYSL, 126(4), 2001, pp. 1579-1587
Authors:
Badros, A
Barlogie, B
Siegel, E
Roberts, J
Langmaid, C
Zangari, M
Desikan, R
Shaver, MJ
Fassas, A
McConnell, S
Muwalla, F
Barri, Y
Anaissie, E
Munshi, N
Tricot, G
Citation: A. Badros et al., Results of autologous stem cell transplant in multiple myeloma patients with renal failure, BR J HAEM, 114(4), 2001, pp. 822-829
Authors:
Badros, A
Barlogie, B
Siegel, E
Morris, C
Desikan, R
Zangari, M
Fassas, A
Anaissie, E
Munshi, N
Tricot, G
Citation: A. Badros et al., Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years, BR J HAEM, 114(3), 2001, pp. 600-607
Authors:
Zangari, M
Anaissie, E
Barlogie, B
Badros, A
Desikan, R
Gopal, AV
Morris, C
Toor, A
Siegel, E
Fink, L
Tricot, G
Citation: M. Zangari et al., Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy, BLOOD, 98(5), 2001, pp. 1614-1615
Authors:
Badros, A
Barlogie, B
Morris, C
Desikan, R
Martin, SR
Munshi, N
Zangari, M
Mehta, J
Toor, A
CottlerFox, M
Fassas, A
Aniassie, E
Schichman, S
Tricot, G
Citation: A. Badros et al., High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions (vol 97, pg 2574, 2001), BLOOD, 98(2), 2001, pp. 271-271
Authors:
Barlogie, B
Desikan, R
Eddlemon, P
Spencer, T
Zeldis, J
Munshi, N
Badros, A
Zangari, M
Anaissie, E
Epstein, J
Shaughnessy, J
Ayers, D
Spoon, D
Tricot, G
Citation: B. Barlogie et al., Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 studyof 169 patients, BLOOD, 98(2), 2001, pp. 492-494
Authors:
Badros, A
Barlogie, B
Morris, C
Desikan, R
Martin, SR
Munshi, N
Zangari, M
Toor, A
Cottler-Fox, M
Fassas, A
Aniassie, E
Schichman, S
Tricot, G
Citation: A. Badros et al., High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions, BLOOD, 97(9), 2001, pp. 2574-2579
Authors:
Clarke, A
Desikan, R
Hurst, RD
Hancock, JT
Neill, SJ
Citation: A. Clarke et al., NO way back: nitric oxide and programmed cell death in Arabidopsis thaliana suspension cultures, PLANT J, 24(5), 2000, pp. 667-677
Authors:
Budson, AE
Daffner, KR
Desikan, R
Schacter, DL
Citation: Ae. Budson et al., When false recognition is unopposed by true recognition: Gist-based memorydistortion in Alzheimer's disease, NEUROPSYCHL, 14(2), 2000, pp. 277-287
Authors:
Burnett, EC
Desikan, R
Moser, RC
Neill, SJ
Citation: Ec. Burnett et al., ABA activation of an MBP kinase in Pisum sativum epidermal peels correlates with stomatal responses to ABA, J EXP BOT, 51(343), 2000, pp. 197-205
Authors:
Desikan, R
Barlogie, D
Sawyer, J
Ayers, D
Tricot, G
Badros, A
Zangari, M
Munshi, NC
Anaissle, E
Spoon, D
Siegel, D
Jagannath, S
Vesole, D
Epstein, J
Shaughnessy, J
Fassas, A
Lim, S
Roberson, P
Crowley, J
Citation: R. Desikan et al., Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities, BLOOD, 95(12), 2000, pp. 4008-4010
Authors:
Aslan, T
Fassas, AT
Desikan, R
Siegel, D
Munshi, NC
Mehta, J
Singhal, S
Barlogie, B
Anaissie, E
Citation: T. Aslan et al., Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy, BONE MAR TR, 24(5), 1999, pp. 505-509
Authors:
Desikan, R
Clarke, A
Atherfold, P
Hancock, JT
Neill, SJ
Citation: R. Desikan et al., Harpin induces mitogen-activated protein kinase activity during defence responses in Arabidopsis thaliana suspension cultures, PLANTA, 210(1), 1999, pp. 97-103
Authors:
Singhal, S
Mehta, J
Desikan, R
Ayers, D
Roberson, P
Eddlemon, P
Munshi, N
Anaissie, E
Wilson, C
Dhodapkar, M
Zeldis, J
Barlogie, B
Siegel, D
Crowley, J
Citation: S. Singhal et al., Antitumor activity of thalidomide in refractory multiple myeloma., N ENG J MED, 341(21), 1999, pp. 1565-1571
Authors:
Desikan, R
Clarke, A
Hancock, JT
Neill, SJ
Citation: R. Desikan et al., H2O2 activates a MAP kinase-like enzyme in Arabidopsis thaliana suspensioncultures, J EXP BOT, 50(341), 1999, pp. 1863-1866
Authors:
Desikan, R
Hagenbeek, D
Neill, SJ
Rock, CD
Citation: R. Desikan et al., Flow cytometry and surface plasmon resonance analyses demonstrate that themonoclonal antibody JIM19 interacts with a rice cell surface component involved in abscisic acid signalling in protoplasts, FEBS LETTER, 456(2), 1999, pp. 257-262
Authors:
Desikan, R
Dhodapkar, M
Siegel, D
Fassas, A
Singh, J
Singhal, S
Mehta, J
Vesole, D
Tricot, G
Jagannath, S
Anaissie, E
Barlogie, B
Munshi, NC
Citation: R. Desikan et al., High-dose therapy with autologous haemopoietic stem cell support for Waldenstrom's macroglobulinaemia, BR J HAEM, 105(4), 1999, pp. 993-996